Vivani Medical, Inc.
General ticker "VANI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $72.2M (TTM average)
Vivani Medical, Inc. follows the US Stock Market performance with the rate: 50.1%.
Estimated limits based on current volatility of 2.0%: low 1.35$, high 1.41$
Factors to consider:
- Total employees count: 44 (+214.3%) as of 2023
- Top business risk factors: Early stage and no commercial products, Manufacturing disruptions, Operational and conduct risks, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.66$, 1.95$]
- 2025-12-31 to 2026-12-31 estimated range: [0.48$, 1.48$]
Financial Metrics affecting the VANI estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -32.04 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 42.37 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.48 < Investing cash flow per share per price, % of -0.86
Short-term VANI quotes
Long-term VANI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $21.24MM | $26.96MM | $24.68MM |
| Operating Income | $-21.24MM | $-26.96MM | $-24.68MM |
| Non-Operating Income | $7.35MM | $1.31MM | $1.19MM |
| R&D Expense | $14.17MM | $16.97MM | $15.74MM |
| Income(Loss) | $-13.89MM | $-25.65MM | $-23.49MM |
| Profit(Loss)* | $-13.89MM | $-25.65MM | $-23.49MM |
| Stockholders Equity | $44.31MM | $20.76MM | $17.61MM |
| Assets | $51.13MM | $45.80MM | $41.56MM |
| Operating Cash Flow | $-18.79MM | $-23.70MM | $-20.79MM |
| Capital expenditure | $0.34MM | $0.89MM | $0.56MM |
| Investing Cash Flow | $-0.34MM | $-0.89MM | $-0.56MM |
| Financing Cash Flow | $63.39MM | $0.13MM | $19.05MM |
| Earnings Per Share** | $-0.36 | $-0.50 | $-0.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.